President Trump just recently proposed to
alter the way physicians and medical facilities obtain repaid when you receive medicines in
their offices. Under the proposition, they will receive a payment based on an index
of global rates. Notoriously low cost compared to the United States. This would certainly seem quite smart. Medication producers would certainly have incentive to elevate their prices abroad and also require those nations to pay their fair share
of advancement prices. We'' d reap the advantages of reduced rates in the United
States, yet there'' s a big danger. Costs are reduced in those countries, because they'' ve been satisfied to say “” Hey, we'' re not raising costs. We don'' t require your medicines.””.
Just 1/3 of new medicines are readily available in Australia; just 2/3 are offered in the.
UK. The risk is those prices don'' t rise. We obtain their rate controls.
as well as lack of access to drugs. It'' s a large gamble.
